Dimebon from Medivation Inc showed some promise in treatment of Alzheimers disease. The results of the research showed that it improves cognition, memory and ADLs (activities of daily life). The effects of the drug seem to last for 18 months as per research.
links research articles in xml file, news
Tags: Alzheimer's, Cognition, Dimebon, Drugs, Medivation, Memory, Pharmacology